Sigma Planning Corp Novartis Ag Transaction History

Sigma Planning Corp

  • $3.32 Billion
  • Q3 2025

A detailed history of Sigma Planning Corp transactions in Novartis Ag stock. As of the latest transaction made, Sigma Planning Corp holds 11,168 shares of NVS stock, worth $1.47 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,168
Previous 5,157 116.56%
Holding current value
$1.47 Million
Previous $624,000 129.49%
% of portfolio
0.04%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$113.5 - $129.73 $682,248 - $779,807
6,011 Added 116.56%
11,168 $1.43 Million
Q2 2025

Aug 05, 2025
BUY
$101.96 - $121.01 $28,752 - $34,124
282 Added 5.78%
5,157 $624,000
Q1 2025

May 01, 2025
BUY
$97.14 - $115.57 $63,820 - $75,929
657 Added 15.58%
4,875 $543,000
Q4 2024

Feb 03, 2025
SELL
$96.78 - $117.18 $97,941 - $118,586
-1,012 Reduced 19.35%
4,218 $410,000
Q3 2024

Nov 01, 2024
SELL
$106.13 - $120.89 $30,565 - $34,816
-288 Reduced 5.22%
5,230 $601,000
Q2 2024

Aug 05, 2024
SELL
$92.57 - $107.37 $36,102 - $41,874
-390 Reduced 6.6%
5,518 $587,000
Q1 2024

May 01, 2024
BUY
$95.27 - $108.47 $337,827 - $384,634
3,546 Added 150.13%
5,908 $571,000
Q4 2023

Feb 01, 2024
SELL
$92.27 - $101.54 $438,651 - $482,721
-4,754 Reduced 66.81%
2,362 $238,000
Q3 2023

Nov 06, 2023
SELL
$94.73 - $105.13 $1,989 - $2,207
-21 Reduced 0.29%
7,116 $724,000
Q2 2023

Aug 01, 2023
SELL
$92.52 - $104.91 $54,494 - $61,791
-589 Reduced 7.62%
7,137 $720,000
Q1 2023

May 05, 2023
BUY
$80.03 - $92.81 $102,678 - $119,075
1,283 Added 19.91%
7,726 $710,000
Q4 2022

Jan 24, 2023
SELL
$75.55 - $92.52 $352,063 - $431,143
-4,660 Reduced 41.97%
6,443 $0
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $2,760 - $3,228
37 Added 0.33%
11,103 $844,000
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $412,745 - $480,562
5,126 Added 86.3%
11,066 $935,000
Q1 2022

Apr 20, 2022
SELL
$80.11 - $90.62 $136,988 - $154,960
-1,710 Reduced 22.35%
5,940 $521,000
Q4 2021

Feb 02, 2022
SELL
$79.7 - $88.13 $329,320 - $364,153
-4,132 Reduced 35.07%
7,650 $669,000
Q3 2021

Oct 28, 2021
BUY
$81.78 - $95.14 $20,445 - $23,785
250 Added 2.17%
11,782 $964,000
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $28,214 - $31,163
-331 Reduced 2.79%
11,532 $1.05 Million
Q1 2021

May 06, 2021
BUY
$83.5 - $98.47 $69,722 - $82,222
835 Added 7.57%
11,863 $1.01 Million
Q4 2020

Feb 09, 2021
SELL
$78.07 - $94.43 $43,094 - $52,125
-552 Reduced 4.77%
11,028 $1.04 Million
Q3 2020

Nov 03, 2020
SELL
$82.14 - $91.0 $14,292 - $15,834
-174 Reduced 1.48%
11,580 $1.01 Million
Q2 2020

Jul 31, 2020
BUY
$80.93 - $91.1 $389,839 - $438,828
4,817 Added 69.44%
11,754 $1.03 Million
Q1 2020

May 01, 2020
SELL
$70.67 - $99.01 $398,790 - $558,713
-5,643 Reduced 44.86%
6,937 $572,000
Q4 2019

Feb 03, 2020
BUY
$84.35 - $95.37 $63,093 - $71,336
748 Added 6.32%
12,580 $1.19 Million
Q3 2019

Nov 01, 2019
SELL
$85.54 - $94.26 $15,995 - $17,626
-187 Reduced 1.56%
11,832 $1.03 Million
Q2 2019

Aug 01, 2019
BUY
$75.4 - $92.8 $155,022 - $190,796
2,056 Added 20.64%
12,019 $1.1 Million
Q1 2019

May 01, 2019
SELL
$75.32 - $86.15 $41,049 - $46,951
-545 Reduced 5.19%
9,963 $958,000
Q4 2018

Jan 31, 2019
BUY
$73.66 - $82.02 $254,053 - $282,886
3,449 Added 48.86%
10,508 $902,000
Q3 2018

Nov 07, 2018
SELL
$66.94 - $77.43 $10,643 - $12,311
-159 Reduced 2.2%
7,059 $608,000
Q2 2018

Aug 02, 2018
BUY
$64.91 - $73.36 $14,150 - $15,992
218 Added 3.11%
7,218 $545,000
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $25,340 - $30,294
360 Added 5.42%
7,000 $566,000
Q4 2017

Feb 07, 2018
BUY
$72.33 - $77.64 $25,315 - $27,174
350 Added 5.56%
6,640 $558,000
Q3 2017

Nov 06, 2017
BUY
$74.14 - $77.27 $466,340 - $486,028
6,290
6,290 $540,000

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email